We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

Carterra to Provide Antibody Screening and Characterization for the Coronavirus Immunotherapy Consortium (CoVIC)

Product News   Apr 01, 2020

 
Carterra to Provide Antibody Screening and Characterization for the Coronavirus Immunotherapy Consortium (CoVIC)
FURTHER INFORMATION
 
 
Advertisement
 

Related Product News

Microfluidics Enables Reliable siRNA Drug Delivery for Inflammatory Diseases and Tumor Targeting

Product News

Researchers are using chips from Dolomite Microfluidics to reliably and consistently produce monodisperse particles for targeted delivery of small interfering RNA (siRNA) therapeutics.

READ MORE

Thermo Fisher Scientific to Showcase New Mass Spectrometry Systems and Software at Virtual ASMS Event

Product News

Thermo Fisher Scientific will provide online programming and virtual exhibits to introduce scientists to a number of new products that build on its Orbitrap platform and expand research applications.

READ MORE

Phase I/II Clinical Trial of COVID-19 Vaccine Begins

Product News

Novavax, Inc., a late-stage biotechnology company developing next-generation vaccines for serious infectious diseases, announced enrollment of the first participants in a Phase 1/2 clinical trial of its coronavirus vaccine candidate, NVX‑CoV2373, a stable, prefusion protein made using its proprietary nanoparticle technology.

READ MORE

Like what you just read? You can find similar content on the communities below.

Biopharma Immunology & Microbiology

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE